Eisai Company, Ltd. (ESALY.PK) Confirms Therapeutic Effects of Lenvatinib in Patients With Melanoma in Strategic Collaboration With Quintiles, Inc. (QTRN) to Develop Eisai Anticancer Compounds
6/19/2013 10:09:31 AM
More...
|
Quintiles, Inc. (QTRN) Named a “Best Place to Work in IT” by Computerworld for Fifth Time
6/18/2013 9:13:59 AM
More...
|
Quintiles, Inc. (QTRN) Receives Award From Patient-Centered Outcomes Research Institute to Compare the Effectiveness of Uterine Fibroid Treatments in Real-World Practice
6/4/2013 10:15:49 AM
More...
|
Quintiles, Inc. (QTRN) Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research
5/21/2013 10:00:09 AM
More...
|
Merck Serono and Quintiles, Inc. (QTRN) Announce Innovative Clinical Development Partnership
5/15/2013 9:54:46 AM
More...
|
Quintiles, Inc. (QTRN) Cutting 400 Jobs Worldwide This Year
5/15/2013 7:45:36 AM
More...
|
Quintiles, Inc. (QTRN) Celebrates IPO on the New York Stock Exchange
5/10/2013 12:51:43 PM
More...
|
Quintiles, Inc. (QTRN)'s $947.4M IPO to Spawn a New Billionaire
5/9/2013 6:54:36 AM
More...
|
Quintiles, Inc. (QTRN) Spinoff NovaQuest Banks $80 Million in Pooled Funder
5/6/2013 9:30:42 AM
More...
|
TPG-Backed Quintiles, Inc. (QTRN) Outlines $790 Million Price in IPO
4/26/2013 8:25:47 AM
More...
|
|